Applications > Protein Production

Production of proteins is required for a variety of drug discovery and cell therapy activities including clinical trials, biotherapeutic antibody and recombinant protein manufacturing, vaccine, viral vector and virus-like particle (VLPs) production, as well as purified proteins for use in biochemical screening and profiling. Transient transfection using MaxCyte scalable electroporation has become a practical solution to the time, labor and cost challenges faced when relying exclusively on stable cell lines. The MaxCyte Scalable Transfection Systems can produce proteins faster than stable cell lines, from both adherent and suspension cell types. Additionally, MaxCyte transfection uses a sterile, contained system, and is compatible with both bench scale and cGMP processing.